Thromboembolic events and bleeding in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.

Ana Isabel Ferrer,José Luis Sánchez,María del Carmen Rodríguez,Carmen Soriano,Luis Alberto Aliaga,Sandra Garcia-Nieto,María del Carmen Cuevas Alonso,Antonio Fernández

Thromboembolic events and bleeding in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.

2012

Ana Isabel Ferrer
José Luis Sánchez
María del Carmen Rodríguez
Carmen Soriano
Luis Alberto Aliaga
Sandra Garcia-Nieto
María del Carmen Cuevas Alonso
Antonio Fernández

e19576 Background: An increased risk of thromboembolic events (TE) and bleeding (Bl) has been observed in some trials among cancer patients (CP) treated with bevacizumab (B) and chemotherapy (QT). ...

Keywords:

Bevacizumab
General surgery
Metastatic carcinoma
Internal medicine
Chemotherapy
Oncology
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations